Back

Effect of statin on right ventricle function in breast cancer patients treated with anthracycline

20 June 2025 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Novel strategies for prevention in cardio-oncology Diagnosis and Management of Cardiovascular Disease in Patients with Cancer CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Professor Ketevan Mindadze

Raymann, Tbilisi (Georgia)

5 More presentations in this session

Presentation thumbnail
Impact of sodium-glucose cotransporter-2 inhibitors on survival in patients with cancer therapy-related cardiac dysfunction
Doctor R. Arsanjani (Scottsdale, US)
Abstract Slides
Presentation thumbnail
Gliflozines in active cancer patients with heart failure: final results on safety and effectiveness in the observational TOSCA trial
Doctor I. Fabiani (Pisa, IT)
Abstract Slides
Presentation thumbnail
Revisiting the role of angiotensin-converting enzyme inhibitors in preventing chemotherapy cancer related cardiac disease in paediatric malignant bone tumours patients
Professor Z. Seliem (Cairo, EG)
Abstract Slides
Presentation thumbnail
Sacubitril/Valsartan and cardiovascular outcomes in cancer patients on anthracycline therapy: a global health research network retrospective analysis
Doctor L. Gioli-Pereira (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Prevention of radiation induced cardiotoxicity in patients with left sided breast cancer: results from a phase 2 clinical trial
Doctor I. Paterson (Ottawa, CA)
Abstract Slides

Access the full session

Session thumbnail
Novel strategies for prevention in cardio-oncology

The Event

Event poster

ESC Cardio-Oncology 2025

20 June - 21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources